ReviewJournal of cardiovascular development and disease2017

The Potential of a Novel Class of EPAC-Selective Agonists to Combat Cardiovascular Inflammation.

Graeme Barker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.